Zdrowie i gospodarka · 10/11/2010

FDA Clears Way for Amphetamine Sulfate Tablets to be Approved via Abbreviated New Drug Applications

The US Food and Drug Administration (FDA) has made a determination that Amphetamine sulfate, 5 and 10 milligram tablets, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of these tablets via abbreviated new drug applications (ANDAs).